Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Triacylglycerol 54:4(FA18:2) (Model 1)

near BUD13 · rs11216103

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−307, with 29 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 7,280 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.229 higher; p = 7 × 10−12.

Where it sits Chromosome 11, band 11q23.3 — between genes, 44.4 kb from BUD13.

How common each version is

AG
Korean KRGDB
A 14.5% · G 85.5%
Korean Korea4K
A 14.7% · G 85.3%
Korean Korea1K
A 14.2% · G 85.8%
Japanese ToMMo
A 22.5% · G 77.5%
Vietnamese
A 22.9% · G 77.1%
World gnomAD
A 7.5% · G 92.5%
World 1000 Genomes
A 11.6% · G 88.4%
World TOPMed
A 7.5% · G 92.5%

By ancestry gnomAD

East Asian
A 21.0% · G 79.0%
European (non-Finnish)
A 6.5% · G 93.5%
African / African American
A 2.1% · G 97.9%
South Asian
A 15.2% · G 84.8%
Admixed American (Latino)
A 15.7% · G 84.3%
Middle Eastern
A 6.1% · G 93.9%
Finnish
A 13.8% · G 86.2%
Ashkenazi Jewish
A 6.4% · G 93.6%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Triacylglycerol 54:4(FA18:2) (Model 1). That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Triacylglycerol 54:4(FA18:2) (Model 1). That is a smaller link than two copies.
G/G No copy of the version the research linked to Triacylglycerol 54:4(FA18:2) (Model 1). This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Triacylglycerol 54:4(FA18:2) (Model 1) (rs11216103). MyGeneLog™. https://www.mygenelog.com/variants/rs11216103

← See all variants